The soul of Khan Al-Khalili in Ramadan at Park Hyatt Jeddah

Guests can enjoy assorted desserts and beverage choices overlooking the Red Sea and the famous King Fahd’s Fountain.
Updated 21 April 2019

The soul of Khan Al-Khalili in Ramadan at Park Hyatt Jeddah

Park Hyatt Jeddah is celebrating the upcoming holy month by elevating the experience of Ramadan for its guests through the nostalgia of Khan Al-Khalili, a historic Arabic souk in Cairo with an authentic soul and heritage of the Middle East.
“Iftar at Nafoura, an award-winning restaurant, will take guests to the ancient lanes of Khan Al-Khalili filled with rows of aromatic spices and vintage goods, including lavish buffets featuring live cooking stations and serving a selection of international, Mediterranean and traditional Hijazi dishes,” the hotel said.
In addition, Andalusia Restaurant will serve iftar featuring a rich selection of international and Mediterranean dishes.
These buffets will also offer a selection of Ramadan’s most popular mezza, soups and desserts.
Guests can extend their stay after iftar in the lounge and enjoy assorted desserts and beverage choices overlooking the Red Sea and the famous King Fahd’s Fountain.
For corporate clients, the resort’s events team will be on hand to assist in planning iftar or sahoor parties in the Lazurde or Al-Sohba ballrooms.
Both are located amidst gardens featuring spacious palm courtyards and facing the Red Sea and King Fahd’s Fountain.
Park Hyatt is also inviting guests to celebrate Eid Al-Fitr with a memorable dining experience.
On the first day of Eid, guests can indulge in a lavish breakfast at the Lazurde ballroom and Nafoura restaurant or an Eid brunch at Nafoura.
For dinner, a special buffet awaits diners at Nafoura, available only on the first three days.
Andalusia Restaurant is offering an exquisite Moroccan experience to diners, also on the first three days only.
The hotel has announced Genesis, Nespresso and Radwa as its partners this Ramadan.


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.